Patients with cystic fibrosis (CF) frequently develop malnutrition, wh
ich is associated with poor pulmonary function, increased incidence of
infection and reduced survival rates. Malnutrition results from a dis
crepancy between high energy demands, primarily due to an increased wo
rk of breathing in patients with limited pulmonary function, and low e
nergy uptake due to malabsorption and inaedaquate food consumption. In
addition to an energy deficit, deficiency of individual nutrients may
develop. Symptomatic protein deficiency occurs mainly in infants and
in older CF patients with severe malnutrition. Salt deficiency with de
hydration or hypochloraemic alkalosis is found primarily in infancy an
d is associated with increased sweat loss. The availability of water s
oluble vitamins is usually not compromised, with the possible exceptio
n of vitamin B-12. In contrast, patients with steatorrhea frequently d
evelop a deficiency of lipid soluble vitamins, therefore, prophylactic
supplementation is required in all CF patients with exocrine pancreat
ic insufficiency. Essential fatty acid status is also poor in many pat
ients. Nutritional therapy in CF follows a stepwise concept and is ada
pted to the individual patient. From the time of diagnosis, regular mo
nitoring of nutritional status and repeated dietary counseling is mand
atory. Subnormal weight gain should prompt early intervention with int
ensified dietary counseling aiming at increased energy intake with hom
e made foods. If the weight response is not adaequate, the use of supp
lemental formula and possibly also of nighttime or continuous gavage f
eeding should be considered.